Adults 11 to 12, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Phenolic Acid Metabolites Measured in Plasma and Urine After Dietary InterventionPrimary· Measurements were conducted hourly for 5 hours; the cumulative number of metabolites characterized over the 5 hours is reported
Fasting Blood and urine were collected at visit two and three following an overnight fasting. At visit three, children consumed a single dose of the study product and plasma and urine were collected
Plasma
Group
Value
95% CI
Wild Blueberry Supplement
13
Placebo Supplement
0
Urine
Group
Value
95% CI
Wild Blueberry Supplement
25
Placebo Supplement
3
Endothelial Function by Brachial Artery Flow Mediated DilationSecondary· up to 2 weeks
Endothelial-dependent flow-mediated vasodilation of the brachial artery in the fasting state was measured using high resolution ultrasound at enrollment and after 5 days on the intervention. This technology uses sound waves (ultrasound) to visualize the diameter of the brachial artery. A baseline image of the brachial artery will be recorded at rest. A blood pressure cuff will be placed around the lower arm and the cuff will be inflated to 50 mmHg above systolic pressure for 5 minutes, followed by rapid deflation of the cuff. The diameter of the brachial artery will be measured from ultrasound
Group
Value
95% CI
Wild Blueberry Supplement
9.4
± 3.4
Placebo Supplement
9.4
± 3.0
Adverse events — posted to ClinicalTrials.gov
Time frame: 1 year, 4 months.
Reporting threshold: 5%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
This is a research study about the effects of blueberries on the health of children who do not eat much fruits and vegetables. By doing this study, we hope to find out what nutrients from blueberries appear in the blood and urine of the child
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06707207 — Predicting Future Errors During Skill Performance
· recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
· Phase 1
· recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
· NA
· recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects
· NA
· recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
· Phase 1, PHASE2
· recruiting
Other Arkansas Children's Hospital Research Institute trials
Trials by the same sponsor.
NCT06929091 — Effect of Prenatal and Postnatal Intervention Strategies on Breastfeeding Outcomes in Women With Excessive Weight (Ready
· NA
· recruiting
NCT06848478 — Level Up! (The Combined and Independent Effects of Exercise Training and Dietary Enhancement on Cardiometabolic Health i
· NA
· not yet recruiting
NCT06666257 — Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study
· NA
· not yet recruiting
NCT07107321 — Deimplementation of Inappropriate Feeding Practices in Early Care and Education Settings
· NA
· enrolling by invitation
NCT07346300 — We-Move With Windy: Gross Motor Development for Early Childhood
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arkansas Children's Hospital Research Institute
Last refreshed: 22 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04421950.